Skip to main content
Aesthetic Surgery Journal Open Forum
by Lisa Orozco
For this post hoc analysis, the authors extracted and analyzed data from the BLESS III study to determine whether there were variances in the effectiveness and safety of letibotulinumtoxinA for treating vertical glabellar lines between the broader female study population and a group of female participants aged 35 to 50.
Aesthetic Surgery Journal Open Forum
by Lisa Orozco
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
Tracy Pfeifer, MD, MS
by Lisa Orozco
In this month’s update, Dr. Tracy Pfeifer highlights the importance of fellowships and residents, how AlliedPro can help evolve staff's education, The Aesthetic Cruise 2026 is almost sold out, and the upcoming Facial and Rhinoplasty Symposium!
Patricia McGuire, MD
by Lisa Orozco
The dues support the 30+ ongoing studies that have been funded by The Foundation including studies such as “Cytotoxicity of Implant-Exposed Serum on Breast Cancer”, “Impact of Xeomin, Dysport, and Botox on Nerve Injuries”, “Effect of Intramuscular Fat Grafting on New Muscle Formation”, “Does TXA reduce Bruising After Hyaluronic Acid Filler Injection: A Prospective half face study”, “Increasing SMAS Durability via Photochemical Passivation for Facelifts”, and “Histologic Effects of Energy-Based Skin Tightening Treatments”.
Tracy Pfeifer, MD, MS
by Lisa Orozco
Dr. Tracy Pfeifer highlights key developments for The Aesthetic Society, including the new impact factor for Aesthetic Surgery Journal, evolving needs across generations of surgeons, plans for The Aesthetic MEET 2026, upcoming participation at ISAPS in Singapore, and an important cybersecurity alert for members.
1 - 10 of 236